Ravuconazole

Ravuconazole is a member of the class of triazoles that is 1-butyl-1H-1,2,4-triazole in which the butyl group is substituted at positions 2, 2, and 3 by hydroxy, 2,4-difluorophenyl, and 4-(p-cyanophenyl)-1,3-thiazol-2-yl groups, respectively (the R,R stereoisomer). It exhibits antifungal activity by inhibition of 14alpha demethylase, an enzyme involved in sterol synthesis, resulting in lysis of the fungal cell wall and fungal cell death. Its therapeutic use is listed as antifungals and dermatologicals. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include BMS-207147, (Benzonitrile, 4-(2-((1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2 and 4-triazol-1-yl)propyl)-4-thiazolyl)-). Its PubChem CID is 467825.

CAS No 182760-06-1
Molecular Formula C22H17F2N5OS
Molecular Weight 437.5 g/mol
Synonyms 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile

Frequently Asked Questions